Funding · Company
Abcuro, Inc.
Newton, MABiotech & Pharma
Abcuro, Inc. of Newton, MA has disclosed $240M across 3 Form D offerings filed with the SEC between Aug 25, 2023 and Aug 13, 2026.
$240M
Total disclosed
3
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$39M
Form D · Aug 13, 2026 ↗
Q3 2026
· target $177M
$80M
Form D · Feb 19, 2025 ↗
Q1 2025
· target $200M
$120M
Form D · Aug 25, 2023 ↗
Q3 2023
· target $200M
Filing details
HeadquartersNewton, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001692147Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →